DARE — Dare Bioscience Share News
0.000.00%
Last trade - 00:00- $12.70m
- $5.98m
- $1.03m
Dare Bioscience Inc reports results for the quarter ended in June - Earnings Summary
Dare Bioscience Inc expected to post breakeven results a share - Earnings Preview
Dare Bioscience Inc expected to post breakeven results a share - Earnings Preview
Brief: Daré Bioscience Announces Reverse Stock Split
Dare Bioscience Inc reports results for the quarter ended in March - Earnings Summary
Brief: Dare Bioscience Files For Common Stock Offering Of Up To $18.1 Mln
Brief: Dare Bioscience To Get $1 Million As Latest Installment Under Grant Deal
Dare Bioscience Inc reports results for the quarter ended in December - Earnings Summary
Dare Bioscience Inc expected to post a loss of 10 cents a share - Earnings Preview
Brief: Daré Bioscience Announces Executive Team And Board Of Directors Changes
Brief: Dare Bioscience Announces Royalty-Backed Financing Agreement
Brief: Daré Bioscience Announces Positive Topline Pharmacokinetic And Exploratory Efficacy Results From The Dare-Pdm1 Phase 1 Clinical Study
Brief: Daré Bioscience Announces Commencement Of Phase 3 Study Of Ovaprene
Brief: Daré Bioscience Announces Additional Positive Data From Phase 2B Respond Study
U.S. STOCKS ON THE MOVE-Overstock.com, Biocept, Birkenstock
Daré to receive milestone payment of $1.8 mln, shares rise
Brief: Daré Bioscience Announces Achievement Of First Commercial Milestone Under License Agreement For XACIATIO (Clindamycin Phosphate) Vaginal Gel
Brief: Daré Bioscience Announces Grant Funding Installment To Support Further Development Of Novel Contraceptive Technology Dare-Larc1
Brief: Daré Bioscience Completes Previously Announced Equity Financing